Microcurrent therapy is ideal for people experiencing: Mild to moderate facial sagging Loss of tone or dullness Hollowed areas post-weight loss It can also be used preventatively during your weight loss journey to help maintain structure as the fat beneath the skin decreases
Beyond weight loss and diabetes, GLP-1 therapies are being studied for conditions such as: Alzheimers and Parkinsons disease Non-alcoholic fatty liver disease (NAFLD) Polycystic ovary syndrome (PCOS) Final Thoughts: GLP-1 as a Metabolic Game Changer GLP-1 is more than just a gut hormone
6 , 7 GLP1 RAs have been available as injectable formulations since exenatide received FDA approval in 2005 and as oral formulations since semaglutide was approved in 2019, 8 trials have demonstrated significant weight and HbA1c reduction benefits of GLP1 RA compared with standard of care in patients with type 2 diabetes at high cardiovascular risk
Have you taken metformin
Additionally, those with severe inflammatory bowel disease (Crohn's disease or ulcerative colitis) may experience worsening diarrhea, nausea, or abdominal cramping, since GLP-1 agonists already cause gastrointestinal side effects in 3050% of users
But as these medications become more widely prescribed, patients are reporting an unexpected side effect: hair loss
